{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-087926","form_type":"8-K","ticker":"RLMD","cik":"0001553643","company_name":"RELMADA THERAPEUTICS, INC.","filed_at":"2025-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.314384+00:00","generated_at":"2026-05-17T06:29:37.413605+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Relmada regains Nasdaq minimum bid price compliance; stock remains listed on Capital Market","bullets":["Received Nasdaq written notice on Sept 15, 2025, confirming compliance with $1.00 minimum bid price rule after 10 consecutive trading days.","Compliance achieved after closing bid price exceeded $1.00 from Aug 29 to Sept 12, 2025; Nasdaq considers matter closed.","Relmada now fully compliant with all Nasdaq continued listing requirements; RLMD remains traded on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-087926","json":"https://secwatch.observer/filing/0001213900-25-087926.json","markdown":"https://secwatch.observer/filing/0001213900-25-087926.md","text":"https://secwatch.observer/filing/0001213900-25-087926.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025087926/0001213900-25-087926-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025087926/ea0257497-8k_relmada.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:29:37.413605+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}